# Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate

> **NCT00540904** · PHASE2 · COMPLETED · sponsor: **Barretos Cancer Hospital** · enrollment: 27 (actual)

## Conditions studied

- Radiographic Contrast Agent Nephropathy

## Interventions

- **DRUG:** sodium bicarbonate
- **DRUG:** NaCl

## Key facts

- **NCT ID:** NCT00540904
- **Lead sponsor:** Barretos Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-08
- **Final completion:** 2009-09
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2014-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00540904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00540904, "Prevention of Contrast Induced Nephropathy in Oncology Patients With Sodium Bicarbonate". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00540904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*